PIVKA-II would be a better biomarker for predicting tumor size in HCC than AFP, since although patients with a tumor size > 3 cm had higher serum levels of both biomarkers, AFP did not correlate with tumor size, whereas PIVKA-II did have a statistically significant positive correlation with tumor size. Here, AFP is linked to hepatocellular carcinoma.